Bitfarms Reschedules First Quarter Conference Call to May 15th at 8:00am ET
May 13, 2024 07:00 ET
|
Bitfarms Ltd.
TORONTO and BROSSARD, Québec, May 13, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin mining company, announces that it will report first...
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
May 13, 2024 06:50 ET
|
Pharvaris N.V.
ZUG, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent...
MKS Instruments Announces Proposed Private Offering of $1.0 Billion of Convertible Senior Notes
May 13, 2024 06:37 ET
|
MKS Instruments, Inc.
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced that it intends to offer, subject to market and other conditions, $1.0 billion aggregate...
Fortrea Reports First Quarter 2024 Results
May 13, 2024 06:30 ET
|
Fortrea Holdings Inc
For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings...
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 13, 2024 06:05 ET
|
AC Immune SA
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update Landmark deal announced with Takeda for ACI-24.060 with $100 million upfront and total potential payments for...
Here’s a Crazy And Clever Marketing Idea: Clothes That Actually Fit
May 13, 2024 06:00 ET
|
Destination XL Group, Inc.
CANTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (Nasdaq: DXLG), the largest integrated commerce specialty retailer of Big + Tall men’s clothing and shoes, announced today...
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
May 13, 2024 06:00 ET
|
Fulcrum Therapeutics, Inc.
― Sanofi receives exclusive rights to commercialize losmapimod in all territories outside the U.S.; Fulcrum retains full U.S. commercialization rights ― ― Fulcrum will receive an upfront payment...
RadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024
May 13, 2024 06:00 ET
|
RadNet, Inc.
LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned...
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
May 13, 2024 06:00 ET
|
Fractyl Health, Inc.
FRACTYL HEALTH PRESENTS CLINICAL UPDATE ON REVITA® GERMAN REAL- WORLD REGISTRY FOR PATIENTS WITH ADVANCED TYPE 2 DIABETES (T2D)
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
May 13, 2024 06:00 ET
|
AC Immune SA
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease Takeda to receive exclusive option to license global rights...